Goat Anti-Rhesus IgG(H+L)-FITC
Referencia 6200-02
embalaje : 1.0mg
Marca : Southern Biotech
Isotype | Goat IgG |
---|---|
Isotype Control | Goat IgG-FITC |
Specificity | Reacts with the heavy and light chains of rhesus IgG |
Source | Pooled antisera from goats hyperimmunized with rhesus IgG |
Cross Adsorption | None; may react with immunoglobulins from other species and the light chains of other rhesus immunoglobulins |
Purification Method | Affinity chromatography on rhesus IgG covalently linked to agarose |
Conjugate | FITC (Fluorescein) |
Buffer Formulation | Phosphate buffered saline containing < 0.1% sodium azide |
Clonality | Polyclonal |
Concentration | 1.0 mg/mL |
Volume | 1.0 mL |
Recommended Storage | 2-8°C; Avoid exposure to light |
Applications | Quality tested applications for relevant formats include - ELISA 1-10 FLISA Other referenced applications for relevant formats include - Immunocytochemistry 4,11,12 Western Blot 13-18 Multiplex 19 |
RRID Number | AB_2796265 |
Documentation
Technical Bulletin Safety Datasheet
Certificate of Analysis Lookup
Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view
- 1. Müller S, Margolin DH, Nara PL, Alvord WG, Köhler H. Stimulation of HIV-1-neutralizing antibodies in simian HIV-IIIB-infected macaques. Proc Natl Acad Sci USA. 1998;95:276-81. (ELISA)
- 2. Méderlé I, Le Grand R, Vaslin B, Badell E, Vingert B, Dormont D, et al. Mucosal administration of three recombinant Mycobacterium bovis BCG-SIVmac251 strains to cynomolgus macaques induces rectal IgAs and boosts systemic cellular immune responses that are primed by intradermal vaccination. Vaccine. 2003;21:4153-66. (ELISA)
- 3. Vajdy M, Singh M, Kazzaz J, Soenawan E, Ugozzoli M, Zhou F, et al. Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intranasal and parenteral immunizations. AIDS Res Hum Retroviruses. 2004;20:1269-81. (ELISA)
- 4. Zhang D, Pan W. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites. Infect Immun. 2005;73:6530-6. (ELISA, ICC)
- 5. Li Y, Shao J, Liu R, Zhou L, Chai L, Li H, et al. Evaluation of long-term toxicity of Ad/hIFN-γ, an Adenoviral vector encoding the human interferon-γ gene, in nonhuman primates. Hum Gene Ther. 2008;19:827-39. (ELISA)
- 6. Mandl JN, Akondy R, Lawson B, Kozyr N, Staprans SI, Ahmed R, et al. Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host. J Immunol. 2011;186:6406-16. (ELISA)
- 7. Gautam R, Nishimura Y, Lee WR, Donau O, Buckler-White A, Shingai M, et al. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIVAD8 in rhesus macaques: implications for use in vaccine studies. J Virol. 2012;86:8516-26. (ELISA)
- 8. Mattar CN, Waddington SN, Biswas A, Johana N, Ng XW, Fisk AS, et al. Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems. Gene Ther. 2013;20:69-83. (ELISA)
- 9. Roy CJ, Brey RN, Mantis NJ, Mapes K, Pop IV, Pop LM, et al. Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection. Proc Natl Acad Sci USA. 2015;112:3782-7. (ELISA)
- 10. Borthwick NJ, Rosario M, Schiffner T, Bowles E, Ahmed T, Liljeström P, et al. Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques. Immun Inflamm Dis. 2015;3:82-93. (ELISA)
- 11. Vigh S, Arimura A, Gottschall PE, Kitada C, Somogyvári-Vigh A, Childs GV. Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), using biotinylated ligands. Peptides. 1993;14:59-65. (ICC)
- 12. Ferraro B, Talbott KT, Balakrishnan A, Cisper N, Morrow MP, Hutnick NA, et al. Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA. Infect Immun. 2013;81:3709-20. (ICC)
- 13. Favre D, Blouin V, Provost N, Spisek R, Porrot F, Bohl D, et al. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol. 2002;76:11605-11. (WB)
- 14. Ling B, Santiago ML, Meleth S, Gormus B, McClure HM, Apetrei C, et al. Noninvasive detection of new simian immunodeficiency virus lineages in captive sooty mangabeys: ability to amplify virion RNA from fecal samples correlates with viral load in plasma. J Virol. 2003;77:2214-26. (WB)
- 15. Evans DT, Bricker JE, Desrosiers RC. A novel approach for producing lentiviruses that are limited to a single cycle of infection. J Virol. 2004;78:11715-25. (WB)
- 16. Apetrei C, Kaur A, Lerche NW, Metzger M, Pandrea I, Hardcastle J, et al. Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. J Virol. 2005;79:8991-9005. (WB)
- 17. Stieger K, Le Meur G, Lasne F, Weber M, Deschamps J, Nivard D, et al. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol Ther. 2006;13:967-75. (WB)
- 18. Lhériteau E, Libeau L, Mendes-Madeira A, Deschamps J, Weber M, Le Meur G, et al. Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectors. Mol Ther. 2010;18:1085-93. (WB)
- 19. Brown EP, Normandin E, Osei-Owusu NY, Mahan AE, Chan YN, Lai JI, et al. Microscale purification of antigen-specific antibodies. J Immunol Methods. 2015 Jun 12. doi: 10.1016/j.jim.2015.06.005. [Epub ahead of print]. (Multiplex)